WCI

RI Related News

비회원이 작성한 글입니다!

글작성시 입력했던 비밀번호를 입력해주세요.

List Next Prev
게시글 내용
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
2018/11/12

 

MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine

 

New market report notes that approximately $10 billion in M&A transactions have occurred over the past four years, with signs indicating continuing future growth.

With the recent announcement by Novartis to acquire Endocyte, interest from the conventional pharmaceutical industry towards radiopharmaceuticals and in particular radiotherapeutics and radiotheranostics is clearly growing, as foreseen a few years ago by MEDraysintell. Numerous major acquisitions have involved the conventional pharmaceutical industry over the past four years.

MEDraysintell noted that other mergers within the radiopharmaceutical industry showed consolidation of this industry. The company said there are great chances that additional mergers and acquisitions (M&A) will take place within the next 12 months. At the same time, the conventional pharmaceutical industry is now looking for new opportunities in early-stage research programs in this area. MEDraysintell anticipates that the global market will reach $5.9 billion in 2019, and it is now expected that radiotherapeutics will represent more than 60 percent of the $26 billion nuclear medicine market by 2030.


To read more please visit:

https://www.itnonline.com/content/medraysintell-projects-increasing-mergers-and-acquisitions-nuclear-medicine

Source: ITN online